Items where Research Area is "Research Areas > Cancer studies"

Up a level
Export as [feed] Atom [feed] RSS
Group by: First Author/Editor | Item Type | Year
Jump to: 2024
Number of items: 8.

2024

Ahmed, M. Yahya, Cakir, Muharrem Okan, Salman, Nadia Aziz, Sandhu, Sarbjinder and Ashrafi, G. Hossein (2024) Concurrent high risk HPV35, HPV45, and HPV59 infections in prostate and bladder cancer tissues of a single patient : a case report. Heliyon, 10(15), e35074. ISSN (online) 2405-8440

Al-Janaby, Tina, Nahi, Narmin, Seddon, Alan, Bagwan, Izhar, Khelwatty, Said and Modjtahedi, Helmout (2024) The combination of afatinib with dasatinib or miransertib results in synergistic growth inhibition of stomach cancer cells. World Journal of Oncology, 15(2), pp. 192-208. ISSN (print) 1920-4531

Caprifico, Anna E., Vaghi, Luca, Spearman, Peter, Calabrese, Gianpiero and Papagni, Antonio (2024) In vitro detection of cancer cells using a novel fluorescent choline derivative. BMC Medical Imaging, 24, p. 316. ISSN (online) 1471-2342

Hesso, Iman, Zacharias, Lithin, Kayyali, Reem, Charalambous, Andreas, Lavdaniti, Maria, Stalika, Evangelia, Ajami, Tarek, Acampa, Wanda, Boban, Jasmina and Nabhani-Gebara, Shereen (2024) Artificial intelligence for optimizing cancer imaging : user experience study. JMIR Cancer, 10, e52639. ISSN (online) 2369-1999

Kobat, Hasan (2024) Cardio-oncology: cardiotoxicity-induced by anti-cancer treatment. (PhD thesis), Kingston University, .

Melhem, Samar (2024) Investigating the requirements for intelligent systems to support people living with and beyond cancer. (PhD thesis), Kingston University, .

Scanlon, James J, Bristow, Aidan P, Chioni, Athina-Myrto and Wren, Stephen P (2024) KISS1R antagonism as a promising anti-cancer approach : an overview on function, molecular mechanisms and therapeutic potential. Journal on Oncology, ISSN (print) 2692-563X

Sherif, Ozlem, Khelwatty, Said, Bagwan, Izhar, Seddon, Alan, Dalgleish, Angus, Mudan, Satvinder and Modjtahedi, Helmout (2024) Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma. Oncology Reports, 52(6), p. 172. ISSN (print) 1021-335X

This list was generated on Sun Dec 22 01:54:33 2024 GMT.